Can Gilead Recover from 3Q?
November 13, 2014 at 15:48 PM EST
Is Gilead Sciences (GILD) in correction mode? Recently at $104.03, the biotech giant fell 2.7% today, extending a slide that began in late October when the stock hit a 52-week high. Gilead has since fallen 11%. RBC analyst Michael Yee attributes the recent weakness to media reports about patents for a rival hepatitis C drug [...]
